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journal homepage: http: / /www.derm-sinica.comCORRESPONDENCEAutologous ﬁbroblast therapy of the scar: A preclinical reportSurgical revision, dermabrasion, and laser therapy have been
developed to improve scar over the past years. However, they
were often associated with undesirable side effects such as
erythema and hyperpigmentation. These side effects can be cir-
cumvented by autologous ﬁbroblast injection, which provides
a better control of the number of cells delivered and the depth of
their placement. In this report, we describe a 31-year-old man pre-
sented with a traumatic forehead scar treated by autologous ﬁbro-
blasts therapy. During 12 months of clinical follow-up,
improvement on the color and the depth of the scar on patient’s
forehead was observed.
A 31-year-old man presented with a traumatic forehead scar
measuring 0.3  6 cm (Figure 1A). He was injured by a broken glass
bottle and thewound on his foreheadwas closed the same daywith
eight stitches (nylon 5.0). The stitches were removed after 5 days
and the patient came to Dr Mainz Clinic the next day. Results of
a physical examination revealed that the lesion was erythematous
edematous with irregular borders and palpation detected the
lesion to be of ﬁbroelastic consistency. After obtaining informed
consent, the patient was included in the Institutional Research
Board-approved autologous ﬁbroblast transplantation therapy. In
brief, the patient underwent a 4-mm posterior-auricular punch
skin biopsy. The skin sample was placed in a cell culture medium
at 4 C and sent to the Maria Von Med-Biotechnology Co., labora-
tory by following good tissue practices (GTPs). The skin sample
was cut into small pieces and incubated overnight with medium
containing dispase and collagenase at 37 C. The next day, isolated
ﬁbroblasts were cultured and multiplied over 8 weeks to produce
107 cells. The patient was given ﬁbroblast injections 8 weeks after
his ﬁrst visit to the clinic and a clinical picture before administering
the ﬁrst injectionwas taken (Figure 1B). Two cycles of live ﬁbroblast
application were performed with an interval of 3 months. Each
cycle consisted of three weekly applications of 107 live ﬁbroblasts
in 3 mL of Ringer’s solution. Each application consisted of 10–15
30-G needle injections with a distance of 0.1–0.2 mm between
them and with a cell suspension of 0.1–0.2 mL in each injection.
No adverse effects were observed during 12 months of clinical
follow-up. Improvement in the color and the depth of the scar on
patient’s forehead was observed (Figure 1C).
Various techniques for scar treatment have been developed over
the past years (e.g., surgical revision, dermabrasion, and laser
therapy).1 Although some of these techniques were helpful in
improving the scar, they were often associated with undesirable
side effects such as erythema and hyperpigmentation.2 These side
effects can be circumvented by autologous ﬁbroblast injection,
which provides a better control of the number of cells delivered
and the depth of their placement. Our pilot study suggested that1027-8117/$ – see front matter Copyright  2012, Taiwanese Dermatological Associatio
http://dx.doi.org/10.1016/j.dsi.2012.10.007autologous ﬁbroblast therapy may be an alternative therapy for
providing a safer and more effective way to minimize the undesir-
able hypertrophic scar formation.
Results of numerous studies have shown that injection of
ﬁbroblasts increases collagen formation, thereby increasing the
thickness and density of dermal collagen without inducing inﬂam-
matory response.3–5 Most importantly, there have been no reports
showing that intradermal injection of autologous ﬁbroblasts can
lead to keloid scarring or hypertrophic scarring.5 These results sug-
gested that proliferation and collagen production of injected ﬁbro-
blasts followed a negatively regulated cell–cell and cell–matrix
contact pathways.
Injection of cultured autologous ﬁbroblasts has been applied in
various treatments, such as wound healing in severely burned
patients,6 vocal fold scars,7 and plastic surgery.3–5 For severe burns,
subcutaneous injection of ﬁbroblasts at the boundaries of surface
accelerated healing and the therapy was effective through less-
ening the scar of a burn and enhancing epithelialization.6 For vocal
fold scars, multiple injections of autologous ﬁbroblasts into the
lamina propria were well tolerated and the mucosal wave grade
improved, and sustained improvements through 12 months were
seen.7 For performing plastic surgery, injections of autologous
ﬁbroblast were safe and effective to produce improvements in rhy-
tids, acne scars, and other dermal defects.3
In summary, autologous ﬁbroblast injection can be considered
as an alternative and useful approach for minimizing and avoiding
hypertrophic scar formation. Higher numbers of ﬁbroblasts were
shown to offer better improvement rates in wound healing.8
However, further studies with different doses of injected ﬁbroblasts
and larger population are required.Funding source
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Figure 1 (A) A 31-year-old man with a deep scar on his forehead. (B) Clinical picture
before the ﬁrst injection. (C) Scar repair after autologous ﬁbroblast therapy.
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